Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Follow ZDNET: Add us as a preferred source on Google. Web browsers are among the most essential pieces of software we use daily, yet we often take them for granted. Most users settle for whatever ...

Migrating legacy Oracle databases to the cloud is a critical step for organizations aiming to modernize their infrastructure and enhance operational efficiency. In this blog post, we’ll walk through a ...

To connect your OnePlus (or even Oppo or Vivo) phone to a Mac using O+ Connect, download the O+ Connect app, install it on your Mac, and ensure both devices are on the same Wi-Fi and Bluetooth is ...

The new browser, called Atlas, is designed to work closely with OpenAI products like ChatGPT. By Cade Metz Reporting from San Francisco OpenAI on Tuesday unveiled a free web browser that is designed ...

Hyperscalers leased approximately 7.4 gigawatts of U.S. data center capacity in the third quarter of this year. That is more capacity than was leased in all of 2024, according to a TD Cowen note ...

Google on Tuesday announced a brand-new AI model called Gemini 2.5 Computer Use, releasing it in preview to developers. If you've been following the AI industry, you might be familiar with the term ...

One of the drawbacks of the digital age and being able to do so many activities online is that your personal information can get stolen. You can access banking online, but your bank accounts and ...

Companies across many industries are implementing AI agents for internal use, automating a wide range of tasks. In the financial sector, AI agents are critical for fraud detection. They can analyze ...

Oracle and OpenAI will develop an additional 4.5 gigawatts of Stargate data center capacity in the U.S. Stargate is a joint venture between OpenAI, Oracle and Softbank that aims to invest up to $500 ...

Feasibility of circulating tumor DNA-based minimal residual disease (ctDNA-MRD)-guided adjuvant chemotherapy in patients with stage II-III gastric cancer (GC): An adaptive trial (MRD-GATE).